The biopharmaceutical company has promising anti-seizure results with their own designed small molecule lead structure in different epilepsy models Planegg / Martinsried (Germany), May 23, 2018 – Epilepsy is a brain disease affecting about 60 million people worldwide. For at …
Prof. David C. Henshall, Prof. Hajo M. Hamer, MD, Prof. R. Jeroen Pasterkamp, PhD, Prof. David B. Goldstein, PhD, Prof. Jørgen Kjems, PhD, Prof. Jochen H. M. Prehn, PhD, Stephanie Schorge, PhD, Kai Lamottke, PhD, Felix Rosenow, MD, THE LANCET …
Dr. Kai Lamottke presents the results on the topic “New miRNA-Modulating Chemical Entities for the Treatment of Epilepsy” as a workpackage leader of EU-project during the 3rd General Assembly of EpimiRNA. Read more from the project coordinator David Henshall of …